Nakamura A, Kubo T,Takai T. Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer[J].Adv Exp Med Boil, 2008, 640: 220-233.
[5]
Magnusson SE, Engstr？m M, Jacob U,et al. High synovial expression of the inhibitory FcγRIIb in rheumatoid arthritis[J].Arthritis Res Ther, 2007, 9(3): 1-11.
[6]
Willcocks LC, Carr EJ, Niederer HA, et al. A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus[J].Proc Natl Acad Ssi USA, 2010, 107(17): 7881-7885.
[7]
Li X, Ptacek TS, Brown EE, et al. Fcγ Receptors: Structure, Function and Role as Genetic Risk Factors in SLE[J].Genes Immun, 2009, 10(5): 380-389.
[8]
Guriec N, Daniel C, Ster KL,et al. Cytokine-regulated expression and inhibitory function of FcγRIIB1 and -B2 receptors in human dendritic cells[J].J Leukoc Biol, 2006, 79(1): 59-70.
[9]
Tzeng SJ, Bolland S, Inabe K, et al. The B cell inhibitory Fc receptor triggers apoptosis by a novel c-Abl family kinase-dependent pathway[J].J Biol Chem, 2005, 280(42):35247-35254.
[10]
Su K, Yang H, Li X, et al. Expression Profile of FcγRIIb on Leukocytes and Its Dysregulation in Systemic Lupus Erythematosus[J].Cli Immun, 2007, 178(5): 3272-3280.
[11]
McGaha TL, Sorrentino B, Ravetch JV. Restoration of Tolerance in Lupus by Targeted Inhibitory Receptor Expression[J].Science, 2005, 307(5709):590-593.
[12]
Werwitzke S, Trick D, Sondermann P, et al. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fcγ receptor II(CD32)[J].Ann Rheum Dis, 2008, 67(2): 154-161.
